Sientra (NASDAQ:SIEN) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a note issued to investors on Friday.
SIEN has been the topic of several other reports. William Blair raised Sientra from a “market perform” rating to an “outperform” rating in a research report on Wednesday, September 13th. Canaccord Genuity started coverage on Sientra in a research report on Monday, August 28th. They set a “buy” rating and a $14.00 price target on the stock. Finally, Stifel Nicolaus reissued a “hold” rating and set a $14.00 price target (up from $11.00) on shares of Sientra in a research report on Wednesday, September 27th. One analyst has rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $13.75.
Shares of Sientra (NASDAQ:SIEN) traded up $0.38 during midday trading on Friday, hitting $15.26. The stock had a trading volume of 133,291 shares, compared to its average volume of 98,066. Sientra has a twelve month low of $7.20 and a twelve month high of $16.68. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.87 and a quick ratio of 1.92.
Hedge funds and other institutional investors have recently modified their holdings of the company. Schroder Investment Management Group increased its holdings in shares of Sientra by 3.5% during the 2nd quarter. Schroder Investment Management Group now owns 432,461 shares of the medical instruments supplier’s stock valued at $4,199,000 after acquiring an additional 14,728 shares during the last quarter. Morgan Stanley boosted its stake in Sientra by 449.6% during the 1st quarter. Morgan Stanley now owns 128,358 shares of the medical instruments supplier’s stock valued at $1,081,000 after purchasing an additional 105,005 shares during the period. Bank of New York Mellon Corp boosted its stake in Sientra by 74.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 90,274 shares of the medical instruments supplier’s stock valued at $877,000 after purchasing an additional 38,514 shares during the period. Schwab Charles Investment Management Inc. bought a new stake in Sientra during the 2nd quarter valued at approximately $252,000. Finally, EAM Investors LLC bought a new stake in Sientra during the 3rd quarter valued at approximately $3,018,000. 76.63% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: This article was first reported by American Banking News and is the property of of American Banking News. If you are reading this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The correct version of this article can be read at https://www.americanbankingnews.com/2017/12/16/sientra-sien-rating-increased-to-hold-at-bidaskclub.html.
Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.
Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.